Safety and Tolerability of Sub-retinal Transplantation of hESC Derived RPE (MA09-hRPE) Cells in Patients With Advanced Dry Age Related Macular Degeneration
Clinical trial NCT01344993 · COMPLETED
Trial details
- NCT number
- NCT01344993
- Sponsor
- Astellas Institute for Regenerative Medicine
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-06-09
- Primary completion
- 2015-08-19
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.